ArticleDupilumab for Off-Label Treatment of Moderate to Severe Childhood Atopic DermatitisAuthor:Emily Jorge, DCNP, FNP-BC, MSNPublish date: August 30, 2018Atopic dermatitis (AD) is a complex chronic pruritic skin disease in which helper T cell (TH2)–type cytokines IL-4 and IL-13 are key con...Read More
